A3173 |
AMD-070 |
558447-26-0 |
98.00% |
CXCR4 antagonist,potent and selective |
A3174 |
AMD-070 hydrochloride |
880549-30-4 |
98.00% |
CXCR4 antagonist,potent and selective |
A3176 |
Ampalex |
154235-83-3 |
98.54% |
Ampakine and nootropic |
A3177 |
AN-2690 |
174671-46-6 |
98.60% |
Antifungal agent |
A3178 |
AN-2728 |
906673-24-3 |
99.33% |
PDE4 inhibitor,anti-inflammatory compound |
A3179 |
Anamorelin |
249921-19-5 |
99.68% |
Ghrelin receptor agonist, synthetic, orally active |
A3182 |
Anguizole |
442666-98-0 |
98.00% |
Inhibitor of HCV replication |
A3184 |
AR-A014418 |
487021-52-3 |
98.34% |
GSK3β inhibitor, ATP-competitive and selective |
A3185 |
AR-C155858 |
496791-37-8 |
99.52% |
MCT1 and MCT2 inhibitor |
A3188 |
ARRY-520 R enantiomer |
885060-08-2 |
98.00% |
KSP inhibitor |
A3189 |
AS 602801 |
848344-36-5 |
98.72% |
Jun Kinase Inhibitor |
A3190 |
ASC-J9 |
52328-98-0 |
98.00% |
AR degradation enhancer,antiumor agent |
A3191 |
Ascomycin(FK 520) |
104987-12-4 |
98.00% |
Macrolide immunosuppressant,FK-520 analog |
A3192 |
Asenapine hydrochloride |
1412458-61-7 |
98.00% |
Atypical antipsychotic |
A3193 |
ASP3026 |
1097917-15-1 |
99.38% |
ALK inhibitor,potent and selective |
A3194 |
AST 487 |
630124-46-8 |
99.29% |
RET kinase inhibitor |
A3195 |
Asunaprevir (BMS-650032) |
630420-16-5 |
99.80% |
NS3 protease inhibitor |
A3196 |
AT-101 |
90141-22-3 |
98.00% |
BH3-mimetic,gossypol enantiomer |
A3197 |
AT7519 Hydrochloride |
902135-91-5 |
99.80% |
Multi-CDK inhibitor |
A3198 |
AT7519 trifluoroacetate |
1431697-85-6 |
98.00% |
CDK/cyclin inhibitor |
A3199 |
AT7867 dihydrochloride |
1431697-86-7 |
98.00% |
Akt1 and p70S6K/PKA inhibitor |
A3201 |
Atrasentan hydrochloride |
195733-43-8 |
98.00% |
Endothelin receptor antagonist |
A3202 |
Avermectin B1 |
71751-41-2 |
98.00% |
Insecticide |
A3206 |
AVL-292 |
1202757-89-8 |
98.27% |
Btk inhibitor |
A3208 |
Avosentan |
290815-26-8 |
98.00% |
ETA receptor antagonist |
A3209 |
AXL1717 |
477-47-4 |
98.07% |
IGF-1R inhibitor,orally active |
A3210 |
AZ20 |
1233339-22-4 |
99.93% |
ATR inhibitor,potent and selective |
A3214 |
AZD1152 |
722543-31-9 |
98.78% |
Aurora B kinase inhibitor,highly potent and selective |
A3215 |
AZD7687 |
1166827-44-6 |
98.00% |
DGAT inhibitor,potent and selective |
A3216 |
Balaglitazone |
199113-98-9 |
99.62% |
PPAR-γ partial agonist |
A3217 |
Balapiravir |
690270-29-2 |
98.00% |
Polymerase inhibitor,anti-HCV |
A3218 |
BAM7 |
331244-89-4 |
98.00% |
BAX activator,direct and selective |
A3219 |
BAN ORL 24 |
475150-69-7 |
98.00% |
NOP receptor antagonist, potent and selective |
A3220 |
Bardoxolone |
218600-44-3 |
99.55% |
Once-a-day treatment for CKD |
A3221 |
Bardoxolone methyl |
218600-53-4 |
98.75% |
IKK inhibitor, potent antioxidant inflammation modulator |
A3222 |
Baricitinib phosphate |
1187595-84-1 |
99.59% |
JAK1/JAK2 inhibitor |
A3227 |
BAY 61-3606 |
732983-37-8 |
98.45% |
Syk Inhibitor |
A3228 |
BAY 61-3606 dihydrochloride |
648903-57-5 |
98.00% |
Syk tyrosine kinase inhibitor |
A3230 |
Bay 65-1942 HCl salt |
600734-06-3 |
98.00% |
IKKβ kinase inhibitor |
A3232 |
Bazedoxifene |
198481-32-2 |
98.00% |
Estrogen receptor modulator |
A3236 |
Benfotiamine |
22457-89-2 |
99.76% |
Drug for painful nerve condition |
A3237 |
Betulinic acid |
472-15-1 |
98.00% |
Anti-HIV and antitumor compound,pentacyclic triterpenoid |
A3238 |
BEZ235 Tosylate |
1028385-32-1 |
98.28% |
MTOR/P13K inhibitor |
A3239 |
B-HT 920 |
36085-73-1 |
98.00% |
D2 receptor agonist |
A3240 |
BIBX 1382 |
196612-93-8 |
98.00% |
EGFR inhibitor,potent and selective |
A3241 |
Bilobalide |
33570-04-6 |
98.00% |
Neuroprotective agent |
A3242 |
Bitopertin |
845614-11-1 |
99.70% |
Glycine reuptake inhibitor(GlyT1) |
A3244 |
Bivalirudin Trifluoroacetate |
128270-60-0 |
98.07% |
Reversible thrombin inhibitor |
A3246 |
BMN-673 8R,9S |
1207456-00-5 |
99.75% |
Inactive form of BMN 673, used as negative control |
A3248 |
BMS345541 hydrochloride |
547757-23-3 |
99.57% |
IKK inhibitor,highly selective |
A3250 |
BMS-509744 |
439575-02-7 |
98.00% |
Itk inhibitor,potent and selective |
A3252 |
BMS-599626 Hydrochloride |
873837-23-1 |
99.58% |
EGFR/HER2 inhibitor,potent and selective |
A3253 |
BMS-626529 |
701213-36-7 |
98.01% |
HIV-1 attachment inhibitor |
A3254 |
BMS-663068 |
864953-29-7 |
98.00% |
HIV-1 attachment inhibitor |
A3256 |
BMS-690514 |
859853-30-8 |
98.00% |
HER/EGFR inhibitor |
A3257 |
BMS-790052 dihydrochloride |
1009119-65-6 |
99.81% |
HCV NS5A inhibitor |
A3258 |
BMS-833923 |
1059734-66-5 |
99.84% |
Smoothened inhibitor |
A3259 |
BMS-927711 |
1289023-67-1 |
98.99% |
CGRP receptor antagonist |
A3260 |
BMX-IN-1 |
1431525-23-3 |
97.99% |
BMX (also termed ETK) kinase inhibitor |
A3261 |
Boceprevir |
394730-60-0 |
98.00% |
HCV protease inhibitor,potent and selective |
A3263 |
BRAF inhibitor |
918505-61-0 |
98.00% |
Potent B-raf inhibitor |
A3264 |
B-Raf inhibitor |
1315330-11-0 |
98.00% |
A B-Raf inhibitor |
A3265 |
Brassinolide |
72962-43-7 |
98.00% |
Plant growth regulator |
A3266 |
BS-181 |
1092443-52-1 |
98.00% |
CDK7 inhibitor,highly selective |
A3268 |
CAL-130 Hydrochloride |
1431697-78-7 |
98.00% |
PI3K inhibitor |
A3270 |
Calcifediol monohydrate |
63283-36-3 |
99.43% |
Prehormone;vitamin D3 metabolite |
A3271 |
Calcipotriol |
112965-21-6 |
98.00% |
Vitamin D3 analog,regulates cell differentiation and proliferation |
A3275 |
Calcium-Sensing Receptor Antagonists I |
478963-79-0 |
98.00% |
CaSR antagonist |
A3276 |
Canertinib dihydrochloride |
289499-45-2 |
99.72% |
Pan-ErbB inhibitor, potent and selective |
A3277 |
Capadenoson |
544417-40-5 |
98.00% |
Adenosine A1 receptor agonist |
A3278 |
Nonivamide (Capsaicin Analog) |
2444-46-4 |
99.53% |
TRPV1 receptor agonist |
A3279 |
Capsazepine |
138977-28-3 |
99.25% |
TRPV1 ion channel antagonist |
A3282 |
Cariprazine |
839712-12-8 |
99.19% |
D2/D3 partial agonist,antipsychotic drug |
A3284 |
Cathepsin S inhibitor |
1373215-15-6 |
98.33% |
Blocks MHCII antigen presentation |
A3285 |
CB 300919 |
289715-28-2 |
98.00% |
Potential therapy for ovarian cancer |
A3286 |
CB30865 |
206275-15-2 |
98.00% |
Nampt inhibitor |
A3287 |
CC-401 hydrochloride |
1438391-30-0 |
98.00% |
JNK inhibitor |
A3288 |
CC-930 |
899805-25-5 |
98.00% |
JNK inhibitor,potent and selective |
A3289 |
CCG-63802 |
620112-78-9 |
98.00% |
RGS protein inhibitor |
A3290 |
CCG-63808 |
620113-73-7 |
98.00% |
Reversible RGS inhibitor |
A3291 |
CCT241533 |
1262849-73-9 |
98.00% |
Potent Chk2 inhibitor |
A3292 |
CCT241533 hydrochloride |
1431697-96-9 |
98.00% |
CHK2 kinase inhibitor, novel |
A3293 |
CDK inhibitor II |
1269815-17-9 |
98.00% |
CDK inhibitor |
A3294 |
CDK9 inhibitor |
1415559-43-1 |
98.00% |
CDK9 inhibitor |
A3295 |
CDK9 inhibitor 2 |
1263369-28-3 |
98.00% |
CDK9 inhibitor |
A3297 |
CEP-32496 hydrochloride |
1227678-26-3 |
98.00% |
B-Raf/C-Raf inhibitor,highly potent |
A3297 |
CEP-32496 hydrochloride |
1227678-26-3 |
98.00% |
B-Raf/C-Raf inhibitor,highly potent |
A3298 |
Cetirizine |
83881-51-0 |
99.65% |
Antihistamine |
A3300 |
Cevimeline hydrochloride hemihydrate |
153504-70-2 |
98.00% |
Agonist of muscarinic receptor (M1/M3) |
A3302 |
CGI-1746 |
910232-84-7 |
98.00% |
Btk inhibitor |
A3303 |
CGP60474 |
164658-13-3 |
98.00% |
CDKs and PKC inhibitor, potent |
A3304 |
CGS 21680 |
120225-54-9 |
98.00% |
Adenosine A2 receptor agonists,potent and selective |
A3305 |
CHAPS |
75621-03-3 |
97.71% |
Zwitterionic detergent for membrane proteins,nondenaturing |
A3306 |
Chelerythrine Chloride |
3895-92-9 |
99.36% |
PKC antagonist |
A3307 |
CHIR-090 |
728865-23-4 |
99.37% |
Potent LpxC inhibitor |
A3308 |
Choline Fenofibrate |
856676-23-8 |
99.92% |
Choline salt of fenofibric acid |
A3309 |
CHR-6494 |
1333377-65-3 |
98.00% |
Haspin inhibitor,potent ands selective |
A3310 |
chroman 1 |
1273579-40-0 |
98.00% |
ROCK II inhibitor, highly potent and selective |
A3311 |
CID-2858522 |
758679-97-9 |
98.00% |
NF-κB pathway inhibitor |
A3313 |
Cinacalcet |
226256-56-0 |
99.48% |
Calcimimetic agent,orally active |
A3314 |
Cinaciguat |
329773-35-5 |
98.00% |
Soluble guanylate cyclase (sGC) activators |
A3315 |
Clemizole |
442-52-4 |
99.06% |
H1 histamine receptor antagonist |
A3316 |
Clemizole hydrochloride |
1163-36-6 |
99.73% |
H1 histamine receptor antagonist |
A3317 |
Clozapine N-oxide (CNO) |
34233-69-7 |
99.74% |
Metabolite of clozapine, used in chemogenetics. |
A3319 |
CMK |
821794-90-5 |
98.00% |
RSK2 kinase inhibitor |
A3320 |
CO-1686 (AVL-301) |
1374640-70-6 |
99.28% |
EGFR inhibitor |
A3321 |
Cobimetinib |
934660-93-2 |
99.71% |
Selective MEK inhibitor |
A3322 |
Cobimetinib (racemate) |
934662-91-6 |
98.00% |
Selective MEK inhibitor |
A3331 |
CP-809101 hydrochloride |
1215721-40-6 |
98.00% |
5-HT2C receptor agonist, potent and selective |
A3334 |
CTS-1027 |
193022-04-7 |
98.00% |
MMPs inhibitor |
A3335 |
Curcumin |
458-37-7 |
98.36% |
Tyrosinase inhibitor |
A3336 |
CVT-313 |
199986-75-9 |
98.04% |
Cdk2 inhibitor |
A3337 |
CX-6258 |
1202916-90-2 |
98.28% |
Pan-Pim kinases Inhibitor |
A3339 |
CYT387 sulfate salt |
1056636-06-6 |
98.00% |
JAK1/JAK2 inhibitor |
A3340 |
CZC24832 |
1159824-67-5 |
98.00% |
Selective PI3K-γ inhibitor |
A3342 |
D4476 |
301836-43-1 |
99.22% |
CK1/ALK5 inhibitor,specific and cell permeable |
A3343 |
D609 |
83373-60-8 |
98.00% |
PC-PLC inhibitor |
A3344 |
D-64131 |
74588-78-6 |
98.00% |
Tubulin polymerization inhibitor |
A3345 |
Dabigatran etexilate mesylate |
872728-81-9 |
99.41% |
Direct thrombin inhibitor,anticoagulant,prodrug of dabigatran |
A3346 |
Dabigatran ethyl ester |
429658-95-7 |
98.00% |
Thrombin activity inhibitor |
A3347 |
Dabrafenib Mesylate (GSK-2118436) |
1195768-06-9 |
99.78% |
Inhibitor of BRAF(V600) mutants |
A3348 |
Daminozide |
1596-84-5 |
98.00% |
KDM2A inhibitor |
A3349 |
Darapladib |
356057-34-6 |
99.54% |
Lp-PLA2 inhibitor, selective and orally active |
A3351 |
Dasatinib hydrochloride |
854001-07-3 |
99.91% |
Multi-BCR/Abl and Src kinase inhibitor, oral active |
A3352 |
Daun02 |
290304-24-4 |
98.00% |
Cell viability inhibitor,DNA synthisis inhibitor |
A3353 |
DB07268 |
929007-72-7 |
98.84% |
JNK1 inhibitor |
A3355 |
Deferasirox Fe3+ chelate |
554435-83-5 |
98.00% |
Oral iron chelator |
A3356 |
Delafloxacin |
189279-58-1 |
99.81% |
Fluoroquinolone antibiotic |
A3357 |
Delafloxacin meglumine |
352458-37-8 |
98.00% |
Fluoroquinolone antibiotic agent |
A3358 |
Deltarasin |
1440898-61-2 |
98.00% |
KRAS-PDEδ interaction inhibitor |
A3359 |
Desmopressin |
16679-58-6 |
98.66% |
Hemostatic and anti-diuretic |
A3360 |
Desmopressin Acetate |
62288-83-9 |
98.73% |
Synthetic analogue of arginine vasopressin |
A3363 |
DGAT-1 inhibitor |
701232-20-4 |
99.64% |
Diacylglycerol acyltransferase (DGAT1) inhibitor |
A3366 |
Dipraglurant |
872363-17-2 |
98.00% |
mGluR5 antagonist |
A3368 |
DMAT |
749234-11-5 |
98.60% |
CK2 inhibitor,potent and selective |
A3369 |
DMP 777 |
157341-41-8 |
98.00% |
Leukocyte elastase (HLE) inhibitor |
A3370 |
Docetaxel Trihydrate |
148408-66-6 |
99.78% |
Depolymerisation of microtubules inhibitor |
A3371 |
Doramectin |
117704-25-3 |
97.08% |
Antiparasitic antibiotic |
A3374 |
Dronedarone |
141626-36-0 |
99.58% |
CYP3A4 and 2D6 inhibitor,moderate |
A3375 |
DY131 |
95167-41-2 |
99.82% |
ERRγ agonist |
A3378 |
E-3810 |
1058137-23-7 |
98.00% |
VEGF/FGF dual inhibitor, potent and selective |
A3380 |
Ebrotidine |
100981-43-9 |
98.00% |
H2-receptor antagonist,competitive |
A3381 |
Edoxaban |
480449-70-5 |
99.27% |
Factor Xa inhibitor |
A3383 |
Edoxaban tosylate monohydrate |
1229194-11-9 |
99.34% |
Oral factor Xa inhibitor |
A3384 |
Elacridar |
143664-11-3 |
98.17% |
BCRP inhibitor |
A3385 |
Elacridar hydrochloride |
143851-98-3 |
98.00% |
BCRP and P-GP inhibitor |
A3387 |
Eltrombopag Olamine |
496775-62-3 |
98.49% |
C-mpl agonist |
A3389 |
EMD638683 |
1181770-72-8 |
98.46% |
SGK1 inhibitor |
A3392 |
Emodin |
518-82-1 |
99.09% |
Naturally occurring anthraquinone,antiproliferative |
A3394 |
Epothilone D |
189453-10-9 |
98.00% |
Natural polyketide compound |
A3395 |
Ercalcidiol |
21343-40-8 |
98.00% |
Vitamin D2 metabolite,ligand of VDR-like receptors |
A3396 |
Ercalcitriol |
60133-18-8 |
98.00% |
Active metabolite of vitamin D2 |
A3397 |
Erlotinib |
183321-74-6 |
99.47% |
EGFR tyrosine kinase inhibitor |
A3399 |
Esomeprazole Magnesium trihydrate |
217087-09-7 |
98.32% |
Proton pump inhibitor |
A3401 |
Etifoxine hydrochloride |
56776-32-0 |
99.87% |
GABAA receptor potentiator |
A3403 |
Etofenamate |
30544-47-9 |
98.05% |
Non-steroidal anti-inflammatory drug |
A3404 |
Etomoxir |
124083-20-1 |
99.75% |
(CPT)-1 and DGAT activity inhibitor |
A3405 |
Etoricoxib |
202409-33-4 |
99.82% |
Specific COX-2 inhibitor |
A3407 |
EVP-6124 hydrochloride |
550999-74-1 |
99.85% |
Alpha7 nAChR agonist |
A3408 |
Exendin-4 |
141758-74-9 |
99.66% |
GLP-1 activator |
A3411 |
Faropenem daloxate |
141702-36-5 |
98.00% |
Oral penem,beta-lactam antibiotic |
A3412 |
Fenretinide |
65646-68-6 |
98.00% |
Synthetic retinoid agonist |
A3413 |
FH535 |
108409-83-2 |
99.62% |
Wnt/B-catenin inhibitor |
A3415 |
Firategrast |
402567-16-2 |
99.56% |
α4β1/α4β7 integrin antagonist |
A3416 |
FK 3311 |
116686-15-8 |
98.00% |
Selective COX-2 inhibitor |
A3417 |
Flavopiridol |
146426-40-6 |
99.52% |
Pan-cdk inhibitor |
A3418 |
Flecainide acetate |
54143-56-5 |
99.82% |
Antiarrhythmic drug |
A3419 |
Fluvastatin |
93957-54-1 |
98.33% |
HMGCR inhibitor |
A3420 |
FMK |
821794-92-7 |
98.82% |
RSK inhibitor |
A3421 |
Fosamprenavir Calcium Salt |
226700-81-8 |
99.71% |
Prodrug of antiretroviral protease inhibitor amprenavir |
A3423 |
Galanthamine |
357-70-0 |
99.12% |
Acetylcholinesterase inhibitor |
A3424 |
Gambogic Acid |
2752-65-0 |
98.54% |
Caspase activator and apoptosis inducer |
A3429 |
GANT 58 |
64048-12-0 |
99.38% |
GLI antagonist,novel and potent |
A3432 |
GDC-0941 dimethanesulfonate |
957054-33-0 |
99.78% |
PI3K inhibitor |
A3433 |
Gefitinib hydrochloride |
184475-55-6 |
99.87% |
Potent EGFR inhibitor |
A3434 |
Genz-644282 |
529488-28-6 |
98.00% |
Non-camptothecin inhibitor of topoisomerase I |
A3435 |
glucagon receptor antagonists 1 |
503559-84-0 |
98.00% |
Glucagon receptor antagonist,highly potent |
A3436 |
glucagon receptor antagonists 2 |
202917-18-8 |
98.00% |
Glucagon receptor antagonist,highly potent |
A3437 |
glucagon receptor antagonists 3 |
202917-17-7 |
98.00% |
Glucagon receptor antagonist |
A3438 |
Glucocorticoid receptor agonist |
1245526-82-2 |
98.00% |
Glucagon receptor antagonist |
A3440 |
Glyoxalase I inhibitor |
221174-33-0 |
98.00% |
Glyoxalase I inhibitor |
A3441 |
GPR120 modulator 1 |
1050506-75-6 |
98.00% |
GPR120 modulator |
A3442 |
GPR120 modulator 2 |
1050506-87-0 |
98.00% |
GPR120 modulator |
A3443 |
Granisetron |
109889-09-0 |
98.00% |
Serotonin 5-HT3 receptor antagonist |
A3444 |
GS-9620 |
1228585-88-3 |
98.01% |
TLR-7 agonist |
A3445 |
GSK 525768A |
1260530-25-3 |
98.00% |
inactive stereoisomer of I-BET-762 |
A3446 |
GSK126 |
1346574-57-9 |
98.32% |
EZH2 inhibitor |
A3448 |
GSK2606414 |
1337531-36-8 |
98.18% |
PERK inhibitor,potent and selective |
A3449 |
GSK343 |
1346704-33-3 |
98.95% |
EZH2 inhibitor,potent,selective and cell permeable |
A3450 |
GSK-923295 |
1088965-37-0 |
98.28% |
CENP-E inhibitor,small-molecule |
A3451 |
Guanfacine hydrochloride |
29110-48-3 |
99.41% |
α2A-adrenoceptor agonist |
A3452 |
GW-1100 |
306974-70-9 |
98.00% |
GPR40 antagonist |
A3453 |
GW1929 |
196808-24-9 |
98.00% |
Potent PPARγ agonist |
A3454 |
GW3965 |
405911-09-3 |
98.00% |
HLXRα/hLXRβ agonist,potent and selective |
A3456 |
GW843682X |
660868-91-7 |
98.00% |
PLK1/PLK3 inhibitor,potent and selective |
A3460 |
HhAntag |
496794-70-8 |
98.95% |
GLI1-mediated transcription inhibitor |
A3461 |
HIV-1 integrase inhibitor |
544467-07-4 |
98.00% |
Uesful for anti-HIV |
A3465 |
HOE 33187 |
23623-08-7 |
98.00% |
Blue fluorescent dyes |
A3466 |
Hoechst 33258 |
23491-45-4 |
99.88% |
Blue fluorescent dyes |
A3472 |
Hoechst 33342 |
875756-97-1 |
98.84% |
Blue fluorescent dyes |